Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026)
Arvinas' Return on Equity [ROE] came in at 1.96% for Q2 2026, up 13.40 percentage points from -11.44% a year earlier and up 55.89 percentage points from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Arvinas' Return on Equity [ROE] was -16.23%, up 16.33 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +10.29 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -32.56% in FY2024 (+27.00 pp), -59.56% in FY2023 (-19.18 pp), -40.38% in FY2022 (-14.52 pp) and -25.86% in FY2021 (+0.66 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] in data going back to Q1 2019.
- Year-over-year, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +19.91 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2025 (a gain of 48.04 percentage points), and the weakest in Q1 2026 (a drop of 46.30 percentage points).
- Business Quant data shows ARVN's Return on Equity [ROE] at -53.93% (Q1 2026), -16.19% (Q4 2025) and -9.97% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Arvinas | 483.87 Mn | -2.17 Bn | - | 1.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96% |
| Mar 31, 2026 | -53.93% |
| Dec 31, 2025 | -16.19% |
| Sep 30, 2025 | -9.97% |
| Jun 30, 2025 | -11.44% |
| Mar 31, 2025 | -7.63% |
| Dec 31, 2024 | -34.66% |
| Sep 30, 2024 | -52.03% |
| Jun 30, 2024 | -53.44% |
| Mar 31, 2024 | -55.67% |
| Dec 31, 2023 | -65.31% |
| Sep 30, 2023 | -63.01% |
| Jun 30, 2023 | -59.41% |
| Mar 31, 2023 | -54.22% |
| Dec 31, 2022 | -45.85% |
| Sep 30, 2022 | -36.84% |
| Jun 30, 2022 | -31.78% |
| Mar 31, 2022 | -27.15% |
| Dec 31, 2021 | -23.03% |
| Sep 30, 2021 | -25.26% |
API Access
Arvinas Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();